Literature DB >> 25331207

Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis.

Jeanine E Roeters van Lennep1, Karst Y Heida2, Michiel L Bots3, Annemieke Hoek4.   

Abstract

AIMS: The purpose of this review was to assess the relationship between premature ovarian insufficiency (POI), defined as natural menopause <40 years, and risk of ischaemic heart disease (IHD), stroke and overall cardiovascular disease (CVD). METHODS AND
RESULTS: We performed a systematic search in PubMed (1966-2012), EMBASE (1980-2012). Studies were included if they were prospective, follow-up>3 years, assessment of age menopause <40 years, and incident cases of fatal or nonfatal IHD, stroke, or overall CVD. Relative risks (RRs) and 95% confidence interval (CI) were pooled using a random-effect model. Overall, 10 observational studies were identified, comprising 190,588 women (follow-up 4-37 years) with 9440 events (2026 events for IHD (seven studies) and 6438 events for stroke (seven studies) and 976 for total CVD (two studies). POI was assessed by questionnaire and incident cases through certification and event registers. POI was related to an increased risk of developing or dying from IHD (hazard ratio (HR) 1.69, 95% CI 1.29-2.21, p = 0.0001) and total CVD (HR 1.61, 95% CI 1.22-2.12, p = 0.0007). No relation was found for stroke (HR 1.03, 0.88-1.19, p = 0.74). We found no evidence for heterogeneity.
CONCLUSION: POI is an independent though modest risk factor of IHD and overall CVD but not of stroke. Because of the limited impact of POI on CVD risk compared to classical cardiovascular risk factors, it is unlikely that POI will be implemented as modifier of cardiovascular risk classification. © The European Society of Cardiology 2014.

Entities:  

Keywords:  Premature ovarian insufficiency; cardiovascular disease; ischaemic heart disease; menopause; meta-analysis; premature ovarian failure; stroke

Mesh:

Year:  2014        PMID: 25331207     DOI: 10.1177/2047487314556004

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  45 in total

1.  Women's Reproductive History and Pre-Clinical Peripheral Arterial Disease in Late Life: The San Diego Population Study.

Authors:  Yamnia I Cortés; Nisha Parikh; Matthew A Allison; Michael H Criqui; Natalie Suder; Emma Barinas-Mitchell; Christina L Wassel
Journal:  J Womens Health (Larchmt)       Date:  2018-12-01       Impact factor: 2.681

2.  The Way to a Woman's Heart: Assessing, Personalizing, and Reclassifying Atherosclerotic Cardiovascular Disease Risk in Female Patients.

Authors:  Jing Liu; Anum Saeed; Aliza Hussain; Salim S Virani
Journal:  Tex Heart Inst J       Date:  2020-04-01

Review 3.  Long-term health consequences of premature or early menopause and considerations for management.

Authors:  S S Faubion; C L Kuhle; L T Shuster; W A Rocca
Journal:  Climacteric       Date:  2015-04-07       Impact factor: 3.005

4.  The Use of Risk Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-society Cholesterol Guidelines.

Authors:  Anandita Agarwala; Jing Liu; Christie M Ballantyne; Salim S Virani
Journal:  Curr Cardiovasc Risk Rep       Date:  2019-05-23

Review 5.  The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.

Authors:  Anandita Agarwala; Erin D Michos; Zainab Samad; Christie M Ballantyne; Salim S Virani
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

Review 6.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

7.  Bempedoic Acid for Lowering LDL Cholesterol.

Authors:  Michael C Honigberg; Pradeep Natarajan
Journal:  JAMA       Date:  2019-11-12       Impact factor: 56.272

8.  The role of ADAMTS4 and ADAMTS9 in cardiovascular disease in premature ovarian insufficiency and idiopathic hypogonadotropic hypogonadism.

Authors:  S Ozler; E Isci Bostanci; E Oztas; M Kuru Pekcan; B Gumus Guler; N Yilmaz
Journal:  J Endocrinol Invest       Date:  2018-09-05       Impact factor: 4.256

Review 9.  Special Considerations for Lipid-Lowering Therapy in Women Reflecting Recent Randomized Trials.

Authors:  Anandita Agarwala; Anne Goldberg
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.113

10.  Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.

Authors:  Michael C Honigberg; Seyedeh M Zekavat; Abhishek Niroula; Gabriel K Griffin; Alexander G Bick; James P Pirruccello; Tetsushi Nakao; Eric A Whitsel; Leslie V Farland; Cecelia Laurie; Charles Kooperberg; JoAnn E Manson; Stacey Gabriel; Peter Libby; Alexander P Reiner; Benjamin L Ebert; Pradeep Natarajan
Journal:  Circulation       Date:  2020-11-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.